Summary
On October 11, 2019, 3M Company announced the completion of its acquisition of Acelity, Inc. for approximately $4.511 billion in cash, subject to certain adjustments. This strategic move marks a significant expansion for 3M, integrating Acelity's advanced wound care solutions into its healthcare portfolio. The acquisition is expected to enhance 3M's competitive position in the healthcare market and contribute to future growth. Investors should note that the transaction was finalized based on the Stock Purchase Agreement dated May 1, 2019. The company also issued a press release on the closing date to disclose this information, which is being furnished as part of this 8-K filing. Further details on the financial implications and integration plans will likely be provided in subsequent filings and investor communications.
Key Highlights
- 13M Company completed the acquisition of Acelity, Inc. on October 11, 2019.
- 2The total cash consideration for the acquisition was approximately $4.511 billion, subject to adjustments.
- 3Acelity is a company specializing in advanced wound care solutions.
- 4The acquisition was made pursuant to a Stock Purchase Agreement dated May 1, 2019.
- 5The company issued a press release on October 11, 2019, to announce the completion of the acquisition.
- 6This acquisition is a significant development for 3M's healthcare business segment.